Myovant Sciences Announces Positive Results from Phase 3 SPIRIT 2 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis and from Ovulation Inhibition Study
Myovant Sciences Ltd. Common Shares (MYOV)
Last myovant sciences ltd. common shares earnings: 2/10 08:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.myovant.com
Company Research
Source: GlobeNewswire
Co-primary endpoints met with 75.2% response rate for dysmenorrhea (menstrual pain) (p and 66.0% response rate for non-menstrual pelvic pain (p Women receiving relugolix combination therapy, on average, had a 75.1% reduction on the Numerical Rating Scale for dysmenorrhea from 7.2 (severe pain) to 1.7 (mild pain)Achieved six key secondary endpoints, including improvement in impact of pain on daily activities and a greater proportion of women not using opioids, with a generally well-tolerated safety profile including minimal bone mineral density loss Demonstrated 100% ovulation inhibition and 100% return of ovulation or menses upon discontinuation of treatment in a separate study Conference call and webcast to be held today at 8:30 a.m. EDT / 5:30 a.m. PDT BASEL, Switzerland, April 22, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women's health and prostate cancer, today announced that SPIRIT 2, the first of two Phase 3
Show less
Read more
Impact Snapshot
Event Time:
MYOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYOV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYOV alerts
High impacting Myovant Sciences Ltd. Common Shares news events
Weekly update
A roundup of the hottest topics